Sun-Bok Jeon

Title: Sun-Bok Jeon: Innovator in Cancer Treatment

Introduction

Sun-Bok Jeon is a notable inventor based in Chungju, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at preventing and treating cancers. His innovative work focuses on the use of diaryl-isoxazole derivatives, which have shown promising results in inhibiting cancer metastasis.

Latest Patents

Sun-Bok Jeon holds a patent for "Pharmaceutical compositions of diaryl-isoxazole derivatives for the prevention and treatment of cancers." This invention relates to a pharmaceutical composition that utilizes diaryl-isoxazole derivatives as an effective ingredient. The derivatives are designed to inhibit the metastasis of breast cancer cell lines and angiogenesis. This makes them potential candidates for use as metastasis inhibitors and in the treatment of various angiogenesis-related diseases, including cancers, rheumatoid arthritis, psoriasis, and eye-related angiogenesis diseases.

Career Highlights

Sun-Bok Jeon is affiliated with the Korea Research Institute of Bioscience and Biotechnology. His work at this esteemed institution has allowed him to focus on groundbreaking research in the field of cancer treatment. His dedication to innovation has led to advancements that could significantly impact patient care and treatment options.

Collaborations

Some of his notable coworkers include Byoung-Mog Kwon and Kwang-Hee Son. Their collaborative efforts contribute to the ongoing research and development in the field of bioscience and biotechnology.

Conclusion

Sun-Bok Jeon's contributions to cancer treatment through his innovative patent highlight the importance of research in pharmaceuticals. His work not only advances scientific knowledge but also holds the potential to improve the lives of many individuals affected by cancer.